Immune responses to plasmid DNA encoding the hepatitis C virus core protein

Journal of Virology

Volumn 69, Issue 9, 1995, Pages 5859-5863

  Lagging, L Martin ^a   Meyer, Keith ^a   Hoft, Daniel ^a   Houghton, Michael ^b   Belshe, Robert B ^a   Ray, Ranjit ^a  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; VACCINE;

ANTIBODY RESPONSE; ARTICLE; GENE AMPLIFICATION; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; IMMUNE RESPONSE; MOLECULAR CLONING; PLASMID; PRIORITY JOURNAL; VIRION; VIRUS INFECTION;

EID: 0029156764     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.69.9.5859-5863.1995     Document Type: Article

References (26)

1. Alter, H. J., R. Purcell, J. Shih, J. Melpolder, M. Houghton, Q. L. Choo, and G. Kuo. 1989. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N. Engl. J. Med. 321:1494.
2. Chien, D. Y., Q. L. Choo, R. Ralston, R. Spaete, M. Tong, M. Houghton, and G. Kuo. 1993. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 342:933.
3. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
4. Cohen, J. 1993. Naked DNA points way to vaccines. Science 259:1691-1692.
5. Cox, G. J. M., T. J. Zamb, and L. A. Babiuk. 1993. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67:5664-5667.
6. Erickson, A. L., M. Houghton, Q. L. Choo, A. J. Weiner, R. Ralston, E. Muchmore, and C. M. Walker. 1993. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J. Immunol. 151:4189-4199.
7. Farci, P., H. J. Alter, D. C. Wong, R. H. Miller, S. Govindarajan, R. Engle, M. Shapiro, and R. H. Purcell. 1994. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl. Acad. Sci. USA 91:7792-7796.
8. Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. 1993. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90: 11478-11482.
9. Hijikata, M., N. Kato, Y. Ootsuyama, M. Nakagawa, and K. Shimotohno. 1991. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. USA 88:5547-5551.
10. Houghton, M., A. Weiner, J. Han, G. Kuo, and Q. L. Choo. 1991. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14:381-388.
11. Hurwitz, E. S., R. S. Holman, J. J. Neal, T. W. Strine, and H. S. Margolis. 1992. Chronic liver disease deaths associated with viral hepatitis in the United States, 1979-1988. Program Abstr. 32nd Intersci. Conf. Antimicrob. Agents Chemother. (Suppl.).
12. Khanna, A., and R. Ray. 1995. Hepatitis C virus core protein: synthesis, affinity purification, and immunoreactivity with infected human sera. Gene 153:185-189.
13. Koziel, M. J., D. Dudley, N. Afdhal, Q.-L. Choo, M. Houghton, R. Ralston, and B. D. Walker. 1993. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67:7522-7532.
14. Koziel, M. J., D. Dudley, J. T. Wong, J. Dienstag, M. Houghton, R. Ralston, and B. D. Walker. 1992. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149:3339-3344.
15. Oldstone, M. B. A., A. Tishon, M. Eddleston, J. C. de La Torre, T. McKee, and J. L. Whitton. 1993. Vaccination to prevent persistent viral infection. J. Virol. 67:4372-4378.
16. Purcell, R. H. 1994. Hepatitis viruses: changing patterns of human disease. Proc. Natl. Acad. Sci. USA 91:2401-2406.
17. Ray, R., V. E. Brown, and R. W. Compans. 1985. Glycoproteins of human parainfluenza type 3 virus: characterization and evaluation as a subunit vaccine. J. Infect. Dis. 152:1219-1230.
18. Ray, R., A. Khanna, L. M. Lagging, K. Meyer, Q.-L. Choo, R. Ralston, M. Houghton, and P. R. Becherer. 1994. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. J. Virol. 68:4420-4426.
19. Robinson, H. L., L. A. Hunt, and R. G. Webster. 1993. Protection against lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11:957-960.
20. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866-9870.
21. Shirai, M., H. Okada, M. Nishioka, T. Akatsuka, C. Wychowski, R. Houghten, C. D. Pendleton, S. M. Feinstone, and J. A. Berzofsky. 1994. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J. Virol. 68:3334-3342.
22. Ulmer, J. B., J. J. Donnelly, and M. A. Liu. 1993. Polynucleotide vaccines. Curr. Opin. Invest. Drugs 2:983-989.
23. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
24. Wang, B., K. E. Ugen, V. Srikatan, M. G. Agadjanyan, K. Dang, Y. Refaeli, A. I. Sato, J. Boyer, W. V. Williams, and D. B. Weiner. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:4156-4160.
25. Wolff, J. A., R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P. L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468.
26. Xiang, Z. Q., S. Spitalnik, M. Tran, W. H. Wunner, J. Cheng, and H. C. J. Ertl. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132-140.